That stance, however, was at odds with its financial support of another group, the American Action Network, which was heavily involved in that effort to put an end to the ACA, often referred to as Obamacare, spending an estimated $10 million on an ad campaign […]
Promises by the pharmaceutical industry to contain prices are a familiar — and fleeting — phenomenon, say analysts who have watched the unstoppable rise in drug costs over the years. Jay Hancock, Kaiser Health News and Sarah Jane Tribble, Kaiser Health News Prescription drug prices […]
“If there is any example of the dysfunction in the American pharmaceutical system, it is this case,” said James Krellenstein, a member of the AIDS advocacy group ACT UP New York. “We have the most effective tool for ending the HIV epidemic, and one reason […]
At a U.S. Senate Health Committee hearing this week, a top administration official tried to say that the decision by the Department of Justice to undo health insurance protections for people with pre-existing conditions had nothing to do with the president’s campaign to rein in […]
By delaying development of generics, drugmakers can maintain their monopolies and keep prices high. Most of the drugs cost Medicare Part D more in 2016 than they did in 2012, for an average spending increase of about 60 percent more per unit. This excludes drugs […]
The pharma industry as a whole has behaved similarly, cranking up political contributions and lobbying. Meanwhile, despite much talk about change, Congress and the Trump administration have done little to control drug prices or threaten drug-company profits. Jay Hancock, Kaiser Health News and Elizabeth Lucas, […]
Pharmaceutical companies are using their savings from recent corporate tax cuts to buy back shares of their own stock, enriching executives and wealthy investors as prescription drug prices continue to skyrocket, says Robert Reich, former Secretary of Labor. “It’s a two part scam,” he said. […]
Seniors are getting financially drained by excessive prescription drug price increases, and a congressional report released this week shows that the situation is unlikely to change anytime soon without fundamental change. The report, “Manufactured Crisis: How devastating drug price increases are harming America’s seniors,” exposed […]
